IL30879A0 - 4-oxa-androstanes and process for the manufacture thereof - Google Patents

4-oxa-androstanes and process for the manufacture thereof

Info

Publication number
IL30879A0
IL30879A0 IL30879A IL3087968A IL30879A0 IL 30879 A0 IL30879 A0 IL 30879A0 IL 30879 A IL30879 A IL 30879A IL 3087968 A IL3087968 A IL 3087968A IL 30879 A0 IL30879 A0 IL 30879A0
Authority
IL
Israel
Prior art keywords
androstanes
oxa
manufacture
Prior art date
Application number
IL30879A
Other versions
IL30879A (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL30879A0 publication Critical patent/IL30879A0/en
Publication of IL30879A publication Critical patent/IL30879A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • G—PHYSICS
    • G11—INFORMATION STORAGE
    • G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B33/00—Constructional parts, details or accessories not provided for in the other groups of this subclass
    • G11B33/02—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
    • G11B33/04—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon modified to store record carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL30879A 1967-11-03 1968-10-16 4-oxa-androstanes and process for the manufacture thereof IL30879A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68030867A 1967-11-03 1967-11-03

Publications (2)

Publication Number Publication Date
IL30879A0 true IL30879A0 (en) 1968-12-26
IL30879A IL30879A (en) 1972-11-28

Family

ID=24730576

Family Applications (1)

Application Number Title Priority Date Filing Date
IL30879A IL30879A (en) 1967-11-03 1968-10-16 4-oxa-androstanes and process for the manufacture thereof

Country Status (14)

Country Link
AT (2) AT287932B (en)
BE (1) BE723189A (en)
BR (1) BR6803654D0 (en)
CH (1) CH505855A (en)
DK (1) DK131576C (en)
ES (1) ES359842A1 (en)
FI (1) FI48098C (en)
FR (2) FR1605466A (en)
GB (1) GB1247022A (en)
IE (1) IE33567B1 (en)
IL (1) IL30879A (en)
NL (1) NL6815623A (en)
NO (1) NO132101C (en)
SE (1) SE352360B (en)

Also Published As

Publication number Publication date
ES359842A1 (en) 1970-06-16
DK131576C (en) 1976-01-05
FI48098C (en) 1974-06-10
IE33567B1 (en) 1974-08-21
IE33567L (en) 1969-05-03
NO132101B (en) 1975-06-09
BE723189A (en) 1969-04-30
NL6815623A (en) 1969-05-06
DE1805857B2 (en) 1977-06-23
AT287932B (en) 1971-02-10
AT297236B (en) 1972-03-10
CH505855A (en) 1971-04-15
FR1605466A (en) 1976-05-14
SE352360B (en) 1972-12-27
DE1805857A1 (en) 1969-06-26
GB1247022A (en) 1971-09-22
IL30879A (en) 1972-11-28
BR6803654D0 (en) 1973-01-16
FI48098B (en) 1974-02-28
DK131576B (en) 1975-08-04
FR8435M (en) 1971-07-15
NO132101C (en) 1975-09-17

Similar Documents

Publication Publication Date Title
IL30429A (en) Isothiocyanatobenzazoles and processes for the production thereof
MY7400317A (en) Halogeno-pregnadienes and process for the manufacture thereof
IL31197A0 (en) Epoxy compounds and process for the manufacture thereof
IL30350A0 (en) Benzodiazepine derivatives and process for the manufacture thereof
MTP565B (en) Sermentation process
IL30346A0 (en) Tricyclic compounds and process for the manufacture thereof
IL31188A0 (en) Epoxides and process for the manufacture thereof
IL30911A0 (en) Tetrahydroisoquinoline derivatives and process for the manufacture thereof
IL29818A0 (en) Benzodiazepine derivatives and process for the manufacture thereof
CY753A (en) Process for the manufacture of alpha-thyrocalcitonin and beta-thyrocalcitonin
IL30487A0 (en) Tetrahydroisoquinoline derivatives and process for the manufacture thereof
MY7100109A (en) Benzenesulphonyl-ureas and process for preparing the
IL31224A0 (en) Epoxy compounds and process for the manufacture thereof
IL30374A0 (en) Benzodiazepine derivatives and process for the manufacture thereof
IL30879A0 (en) 4-oxa-androstanes and process for the manufacture thereof
IL28748A (en) N1-isoxazolyl-sulfanilamides and process for the manufacture thereof
IL31159A0 (en) New substituted benzamidines and process for the preparation thereof
CA759993A (en) Polyeneketones and process for the manufacture thereof
CA756609A (en) Azapentanols and process for the manufacture thereof
CA752405A (en) Aminoisoxazoles and process for the manufacture thereof
IL29884A0 (en) Novel 1-sec-aminocyclopropacyclo-alkanes and process for making them
IL24853A (en) Dihydrodibenzocycloheptene compounds and process for the manufacture thereof
IL24852A (en) Dihydrodibenzocycloheptene compounds and process for the manufacture thereof
PH9259A (en) 3-4-0-arylidene 7-halo-7-deoxy-lincomycin-2-acylates and process for the preparation thereof
IL29927A0 (en) Process for manufacturing 2,6-dichloro-benzamide and the 2,6-dichlorobenzo-nitrile that can be obtained therefrom